Manufacturer record
Windlas Biotech Limited (Plant-2): regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Windlas Biotech Limited (Plant-2) (Uttarakhand) were declared Not of Standard Quality between October 2023 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: NHV26001, Esomeprazole Gastro-Resistant Tablets IP 40 mg (exp Feb 2028). DTL, Thrissur (state lab) found it not of standard quality: The sample does not conform to IP standards with respect to the test Dissolution. Listed in the September 2026 alert.
Records by type
9 records linked to Windlas Biotech Limited (Plant-2) in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Esomeprazole Gastro-Resistant Tablets IP 40 mg | Batch NHV26001Mfg Mar 2026 · Exp Feb 2028 | The sample does not conform to IP standards with respect to the test Dissolution.Dissolution | DTL, ThrissurState lab | Sep 2026 |
| Chlorhexidine Mouthwash IP | Batch WOR25041GMfg Dec 2025 · Exp Nov 2028 | The sample does not conform to claim as per I.P. 2022 with respect of test for Assay of Chlorhexidine Gluconate.Assay | RDTL, GuwahatiCDSCO lab | Jul 2026 |
| Tolperisone Hydrochloride 150 mg and Diclofenac Sodium 50 mg | Batch WON24021GMfg Nov 2024 · Exp Oct 2026 | ContentOther | DTL, Madurai-19State lab | Jun 2026 |
| Lorazepam Tablets IP 1mg, | Batch 5071TNIMfg Apr 2025 · Exp Mar 2028 | The particular sample fails the tests Dissolution and Assay.Assay | RDTL ErnakulamState lab | Jan 2026 |
| Trypsin-Chymotrypsin Tablets (CHYMORAL FORTE DS) | Batch WBB1E020Mfg Dec 2024 · Exp Nov 2026 | The sample is not of standard quality for the reason stated under 'Description'.Description | CDL, KolkataCDSCO lab | Oct 2025 |
| Coscopin Cold Plus | Batch CSP2300 1Mfg Jun 2023 · Exp May 2025 | Sample does not conform to Label claim with respect to the content of Phenylephrine HydrochlorideLabelling | DTL MaduraiState lab | Jan 2025 |
| Pantacea 40 Tablets and Pantoprazole Gastro Resistant Tablets IP 40mg | Batch PNTC3007Mfg Nov 2023 · Exp Oct 2025 | The sample Does not complies in respect of Dissolution Test as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab | Dec 2024 |
| Telmisartan and Amlodipine Tablets IP (Zensartan-AM Tablets) | Batch WEL22031Mfg Apr 2022 · Exp Sep 2024 | Assay of Amlodipine Besilate calculated as AmlodipineAssay | RDTL ChandigarhCDSCO lab | Dec 2023 |
| Etamsylate Tablets 250 mg (Fixoheam-250) | Batch WF123001GMfg Mar 2023 · Exp Feb 2025 | HardnessOther | CDTL MumbaiCDSCO lab | Oct 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.